Viewing Study NCT01333943



Ignite Creation Date: 2024-05-05 @ 11:27 PM
Last Modification Date: 2024-10-26 @ 10:34 AM
Study NCT ID: NCT01333943
Status: COMPLETED
Last Update Posted: 2022-05-11
First Post: 2011-04-08

Brief Title: Saphenous Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty
Sponsor: Hospital for Special Surgery New York
Organization: Hospital for Special Surgery New York

Study Overview

Official Title: Saphenous Adductor Canal Nerve Block Versus Femoral Nerve Block for Total Knee Arthroplasty A Novel Approach for Postoperative Analgesia
Status: COMPLETED
Status Verified Date: 2022-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Currently the regional anesthetic standard of care for total knee replacement surgery is combined spinalepidural with or without a femoral nerve block or FNB Lasting approximately 18 hours the FNB works by numbing the femoral nerve and its branches which is the major nerve controlling the knee joint The femoral nerve also provides movement and sensation While this regional anesthetic technique offers significant postoperative pain relief it is possible that it may cause muscle weakness and increase patients recovery time Hence there is a need for an alternative technique one that may help minimize postoperative pain as effectively as the FNB while not causing weakness of the quadriceps muscle

The saphenous nerve a branch of the femoral nerve provides sensation to the knee Thus it is hypothesized that by blocking or anesthetizing the saphenous nerve with local anesthetic closer to where it branches off the area around and below the knee will feel numb Yet unlike with the FNB the quadriceps muscle itself will still be able to function

Patients will be randomized to receive FNB or saphenous nerve block Quadriceps strength will be tested using a dynamometer before surgery baseline 6-8 hours following anesthesia administration and on postoperative days 1 and 2 It is hypothesized that patients who receive FNB will experience a 50 decrease in quadriceps strength compared to baseline
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None